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Tuberculosis is an infectious disease caused by the 
bacteria Mycobacterium tuberculosis. This disease 
primarily affects the lungs but can also affect 
meninges, bones and joints, lymph glands, 
intestine, skin and other tissues of the human 
body. Tuberculosis is usually chronic in nature 
with varying clinical expressions. Pulmonary 
tuberculosis is the most important and common 
form of tuberculosis which affects man.1 
 
It is the world's leading infectious killer disease, 
claiming almost 5,000 lives every day.2 Every year, 
World Tuberculosis Day is recognized as an event 
on March 24 to commemorate the date when 
Robert Koch discovered Mycobacterium 
tuberculosis, the tuberculosis causing bacillus in 
the year 1882. Although TB is a preventable and 
curable disease, many people in the world still 
suffer from this disease. The current efforts to find 
and treat TB infection  are not adequate. 
Misdiagnosis of TB is still an issue with healthcare 
professionals.3 
 
Despite the fact that the causative organism was 
discovered more than a century ago and highly 
effective drugs and vaccine are available making 
tuberculosis a preventable and curable disease, 
tuberculosis remains a worldwide public health 
problem.1 
 
The transmission of tuberculosis mainly occurs by 
droplet infection and nuclei generated by sputum-
positive patients. For transmission of infection, 
the particles must be fresh enough to carry a viable 
organism. This is also influenced by the frequency 
and vigour of cough and the ventilation of the 
environment. Tuberculosis is not transmitted by 
fomites used by the patients.1 
 
There are two TB-related conditions: latent TB 
infection and TB disease. Subjects carrying latent 
TB infection do not show symptoms and they 
cannot spread the bacteria to others. However, if 
TB bacteria become active in the body, they tend 
to multiply, transforming latent TB infection to 
being sick with TB disease. To avoid this, people 
with latent TB infection are often prescribed 
treatment to prevent them from developing TB 
disease. Treatment of latent TB infection is 
essential for controlling and eliminating TB and 
this should be initiated after the possibility of TB 
disease has been excluded. TB bacteria become 
active if the immune system can’t stop them from 
growing. When TB bacteria are active (multiplying 
in your body), this is called TB disease. People with 
TB disease are sick. They may also be able to 
spread the bacteria to people they spend time with 
every day. The common symptoms of tuberculosis 
include bad cough that lasts few weeks or longer, 
pain in the chest, blood in sputum, weakness, 
fatigue, weight loss, loss of appetite, chills, fever 
and sweating at night.3 
 
Overall, about 5 to 10% of infected persons who do 
not receive treatment for latent TB infection will 
develop TB disease at some time in their lives. For 
persons whose immune systems are weak, 
especially those with HIV infection, the risk of 
developing TB disease is much higher than for 
persons with normal immune systems.3 
 
TB is the world’s leading cause of death from an 
infectious disease, especially among women and 
children. The World Health Organization 
estimates that more than 1.8 million people 
worldwide died of TB in 2015. The symptoms of the 
disease, which is transmitted through the air and 
primarily affects the lungs, often begin with 
coughing, shortness of breath or swollen lymph 
nodes — but can end in death if left untreated. 
People with HIV are especially vulnerable: of 
deaths among people co-infected with HIV and 
TB, about one quarter are due to TB. Five to 10 
percent of these latent TB carriers risk developing 
active TB at some point in their lifetimes. For 
latent TB carriers who are infected with HIV, this 
risk is approximately 10 percent per year. Finally, 
it is important to note that smoking substantially 
increases TB disease occurrence and risk of death 
due to TB worldwide.4  
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The prevention component of control is the BCG 
vaccine whereas the curable components consists 
of chemotherapy namely rifampicin, isoniazid, 
ethambutol, streptomycin, pyrazinamide and 
thioacetazone.  
 
World TB Day provides the platform for affected 
persons and communities, civil society 
organizations, health-care providers, policy 
makers, development partners and others to 
advocate, discuss and plan further collaboration to 
fulfil the promise of reaching all people with 
quality TB prevention and care services, as well as 
enabling TB prevention through multisectoral 
development efforts.5 
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